Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00064857 · ClinicalTrials.gov registry record · Phase 2
Pycnogenol for the Treatment of Lymphedema of the Arm in Breast Cancer Survivors
A Phase 2 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 2
- Development phase
- 26
- Enrollment target
NCT00064857 is a Phase 2 study that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 26 participants.
The verdict
NCT00064857, a Phase 2 study, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 26 participants
- Enrollment target
Study Summary
The goal of this study is to evaluate the effectiveness of a standardized botanical extract of Pycnogenol as a treatment for stable arm lymphedema in breast cancer survivors.
Interventions
- DRUG Pycnogenol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2003-08 |
| Est. Completion | 2007-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00064857
The ClinicalTrials.gov registry entry for NCT00064857 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Center for Complementary and Integrative Health (NCCIH), which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pycnogenol is the first listed.
NCT00064857 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00064857 about?
NCT00064857 is a clinical study titled "Pycnogenol for the Treatment of Lymphedema of the Arm in Breast Cancer Survivors". The goal of this study is to evaluate the effectiveness of a standardized botanical extract of Pycnogenol as a treatment for stable arm lymphedema in breast cancer survivors.
What is the current status of trial NCT00064857?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 26 participants. The study started on 2003-08. Estimated completion is 2007-08.
What interventions are being tested in trial NCT00064857?
The interventions under investigation include: Pycnogenol (DRUG).
Who is sponsoring clinical trial NCT00064857?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.